Abbott Says Nutritionals Can Succeed Without M&A Activity
This article was originally published in The Tan Sheet
Abbott Laboratories executives say its nutritionals business is staying put and can succeed without mergers and acquisitions, despite dragging U.S. sales.
You may also be interested in...
Germany’s Merck KGaA could join the ranks of firms like Pfizer potentially looking to leave the consumer health care product business, market analysts argue.
Abbott Nutrition eyes U.S. launches
Consumer response to Abbott Laboratories' recall of powder Similac and other infant formula products initially exceeded the firm's capabilities to handle telephone calls and support online traffic to its websites